Vaccine for COVID-19 | NEW Paper NEJM with Phase I Clinical Trial for mRNA-1273 Coronavirus Vaccine

Vaccine for COVID-19 | NEW Paper NEJM with Phase I Clinical Trial for mRNA-1273 Coronavirus Vaccine

Omicron-Containing Covid-19 Vaccine | NEJMПодробнее

Omicron-Containing Covid-19 Vaccine | NEJM

One vaccine dose and two viral variantsПодробнее

One vaccine dose and two viral variants

mRNA Covid-19 Vaccination in U.S. Health Care Personnel | NEJMПодробнее

mRNA Covid-19 Vaccination in U.S. Health Care Personnel | NEJM

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine | NEJMПодробнее

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine | NEJM

BNT162b2 Vaccine Booster and Mortality | NEJMПодробнее

BNT162b2 Vaccine Booster and Mortality | NEJM

Pfizer COVID 19 Vaccine results: NEJMПодробнее

Pfizer COVID 19 Vaccine results: NEJM

COVID-19 Vaccines: A Crash CourseПодробнее

COVID-19 Vaccines: A Crash Course

Vaccines Update, NEJM Weighs InПодробнее

Vaccines Update, NEJM Weighs In

Covid VaccineПодробнее

Covid Vaccine

Pfizer Vaccine Study | NEJM December 2020Подробнее

Pfizer Vaccine Study | NEJM December 2020

CORONAVIRUS VACCINE for COVID19! Moderna's Phase I Clinical Trial ResultsПодробнее

CORONAVIRUS VACCINE for COVID19! Moderna's Phase I Clinical Trial Results

The COVID Vaccine: When Will It Be Ready?Подробнее

The COVID Vaccine: When Will It Be Ready?